PRKCSH contributes to TNFSF resistance by extending IGF1R half-life and activation in lung cancer
Article in Experimental & Molecular Medicine (January 2024)
The most recent citing publications are shown below. View all 38 publications that cite this research output on Dimensions.
Article in Experimental & Molecular Medicine (January 2024)
Article in Drug Discovery Today (September 2023)
Article in JAMA Network Open (July 2023)